Effects of 12-Week Methylphenidate Treatment on Neurometabolism in Adult Patients with ADHD: The First Double-Blind Placebo-Controlled MR Spectroscopy Study

Attention deficit hyperactivity disorder (ADHD) is a frequent neurodevelopmental disorder that often persists into adulthood. Methylphenidate (MPH) is the first-line treatment for ADHD; however, despite its wide usage, little is known about its neurometabolic effects. Until now, no randomized and bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Maier, Simon, Tebartz van Elst, Ludger, Philipsen, Alexandra, Lange, Thomas, Feige, Bernd, Glauche, Volkmar, Nickel, Kathrin, Matthies, Swantje, Alm, Barbara, Sobanski, Esther, Domschke, Katharina, Perlov, Evgeniy, Endres, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464267/
https://www.ncbi.nlm.nih.gov/pubmed/32796630
http://dx.doi.org/10.3390/jcm9082601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464267/
https://www.ncbi.nlm.nih.gov/pubmed/32796630
http://dx.doi.org/10.3390/jcm9082601

Ejemplares similares